Share
Chris Smith
Laborie Medical Technologies Corp., a global leader in medical technology solutions, has appointed Chris Smith as Chief Executive Officer.
Smith succeeds Michael Frazzette, who recently announced his retirement after successfully leading the company through a phase of strong growth and innovation.
Chris Smith brings more than 30 years of executive leadership experience in the healthcare and medical technology sectors. He has served as Chief Executive Officer at several prominent organizations, including NeoGenomics Laboratories, Ortho Clinical Diagnostics, and Cochlear Limited.
Across these roles, he has been widely recognized for driving transformative growth, scaling global operations, and fostering innovation in patient care. In addition to his CEO roles, Smith has held multiple board positions across both private and public companies, further deepening his expertise in guiding organizations through complex healthcare markets.
Smith has been a member of Laborie’s Board of Directors since 2023, providing strategic insight during a period marked by significant global expansion and portfolio development.
His close familiarity with Laborie’s mission, culture, and operations makes him well-positioned to lead the company into its next phase of growth.
